Lutherville, Maryland Clinical Trials

A listing of Lutherville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 63 clinical trials
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

Mercy Medical Center -Weinberg Center
 (9.4 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
GNOS-PV02 Personalized Neoantigen Vaccine INO-9012 and Pembrolizumab in Subjects With Advanced HCC

This is a single-arm, open-label, multi-site Phase I/IIa study of a personalized neoantigen DNA vaccine (GNOS-PV02) and plasmid encoded IL-12 (INO-9012) in combination with pembrolizumab (MK-3475) in subjects with histologically or cytologically confirmed diagnosis of HCC based on pathology report.

antiviral drugs
measurable disease
serum pregnancy test
sorafenib
cancer
Johns Hopkins Hospital
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Treatment of Moderate to Severe Lateral Canthal Lines

The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe LCL.

Facial Plastic Surgicenter, Ltd
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

This research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research will determine if …

Johns Hopkins University
 (2.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

covid-19
acute respiratory syndrome (sars)
SARS
pneumonia
acalabrutinib
Research Site
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Study of Safety Tolerability and PK PD of HPG1860 in Healthy Subjects

This is a randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HPG1860 orally administered in healthy subjects.

Pharmaron CPC InC
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

hypertension
cardiovascular disease
gastrointestinal symptoms
lung disease
pharyngitis
The Johns Hopkins Hospital
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

squamous cell carcinoma
pemetrexed
platelet count
cisplatin/gemcitabine
kaposi sarcoma
Sinai Hospital of Baltimore
 (7.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

progranulin
aphasia
pick's disease
dementia
Johns Hopkins University School of Medicine
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

electrocardiogram (ecg)
electrocardiogram
combination therapy
covid-19
acute respiratory syndrome (sars)
Coronavirus Research Institute-Testing Site
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations